Intellia TherapeuticsNTLA
那斯達克 · USD
12.20
-0.69
(-5.35%)
收盤 06/11 03:59 (UTC+8)
盤後
12.22
+0.02
(+0.16%)
06/11 03:59 (UTC+8)
Intellia TherapeuticsNTLA
12.20
-0.69
(-5.35%)
財務數據
損益表
- -0.02
- 0.29
- 0.07
- 0.09
- 0.13
- 0.17
- 0.14
- 0.14
- 0.23
- 0.15
- -
- -
- -75.96
- 30.96
- 41.30
- 29.15
- -14.33
- -3.25
- 67.01
- -34.62
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 15,048 | 23,017 | 13,782 | 14,245 | 16,627 | 12,874 | 9,111 | 6,957 | 28,935 | -1,917 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 15,048 | 23,017 | 13,782 | 14,245 | 16,627 | 12,874 | 9,111 | 6,957 | 28,935 | -1,917 |
營業費用 | 115,580 | 121,727 | 125,259 | 124,241 | 137,434 | 149,321 | 153,881 | 146,000 | 142,938 | 137,975 |
研發費用 | 80,737 | 88,652 | 94,747 | 97,035 | 108,427 | 116,877 | 123,380 | 114,207 | 111,847 | 108,981 |
推銷及管理費用 | 34,843 | 33,075 | 30,512 | 27,206 | 29,007 | 32,444 | 30,501 | 31,793 | 31,091 | 28,994 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -100,532 | -98,710 | -111,477 | -109,996 | -120,807 | -136,447 | -144,770 | -139,043 | -114,003 | -139,892 |
其他收入及費用 | 4,301 | 2,924 | 10,153 | 8,741 | 6,478 | 7,549 | 9,058 | -7,932 | 6,567 | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -96,231 | -95,786 | -101,324 | -101,255 | -114,329 | -128,898 | -135,712 | -146,975 | -107,436 | -132,161 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -96,231 | -95,786 | -101,324 | -101,255 | -114,329 | -128,898 | -135,712 | -146,975 | -107,436 | -132,161 |
基本每股稅後盈餘(元) | -0.81 | -0.83 | -0.92 | -0.98 | -1.10 | -1.27 | -1.34 | -1.52 | -1.12 | -1.46 |
稀釋每股稅後盈餘(元) | -0.81 | -0.82 | -0.92 | -0.98 | -1.10 | -1.26 | -1.35 | -1.52 | -1.12 | -1.46 |
基本平均股數(千股) | 118490.00 | 115921.00 | 110188.00 | 103732.00 | 103500.00 | 101855.00 | 101002.00 | 96975.00 | 95502.00 | 90461.00 |
稀釋平均股數(千股) | 118490.00 | 115921.00 | 110188.00 | 103732.00 | 103500.00 | 101855.00 | 101002.00 | 96975.00 | 95502.00 | 90461.00 |
還原基本每股稅後盈餘(元) | -0.81 | -0.83 | -0.92 | -0.98 | -1.10 | -1.27 | -1.34 | -1.52 | -1.12 | -1.46 |
還原稀釋每股稅後盈餘(元) | -0.81 | -0.82 | -0.92 | -0.98 | -1.10 | -1.26 | -1.35 | -1.52 | -1.12 | -1.46 |
還原基本平均股數(千股) | 118,490 | 115,921 | 110,188 | 103,732 | 103,500 | 101,855 | 101,002 | 96,975 | 95,502 | 90,461 |
還原稀釋平均股數(千股) | 118,490 | 115,921 | 110,188 | 103,732 | 103,500 | 101,855 | 101,002 | 96,975 | 95,502 | 90,461 |
EBITDA(千元) | -94,564 | -90,597 | -97,473 | -100,448 | -114,111 | -129,934 | -137,385 | -149,025 | -110,209 | -129,695 |